NNNN — Anbio Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual balance sheet for Anbio Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	20-F
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.18	8.67	9.69	11.8
Net Total Accounts Receivable
Net Total Receivables	0.718	—	1.88	1.06
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.92	13.9	15.7	18.5
Net Property, Plant And Equipment	0	0.012	0	—
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4.92	14	15.8	18.9
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.38	1.41	0.993	1.73
Total Long Term Debt
Total Debt
Total Liabilities	2.38	1.41	0.993	1.73
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.54	12.5	14.8	17.2
Total Liabilities & Shareholders' Equity	4.92	14	15.8	18.9
Total Common Shares Outstanding